nodes	percent_of_prediction	percent_of_DWPC	metapath
Rasagiline—CYP1A2—chronic obstructive pulmonary disease	0.708	1	CbGaD
Rasagiline—BCL2—respiratory system—chronic obstructive pulmonary disease	0.00401	0.199	CbGeAlD
Rasagiline—BCL2—connective tissue—chronic obstructive pulmonary disease	0.00353	0.175	CbGeAlD
Rasagiline—BCL2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00323	0.16	CbGeAlD
Rasagiline—CYP1A2—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00312	0.0585	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—ELANE—chronic obstructive pulmonary disease	0.00237	0.0444	CbGpPWpGaD
Rasagiline—BCL2—lung—chronic obstructive pulmonary disease	0.00213	0.106	CbGeAlD
Rasagiline—BCL2—Overview of nanoparticle effects—HMOX1—chronic obstructive pulmonary disease	0.00201	0.0378	CbGpPWpGaD
Rasagiline—MAOB—respiratory system—chronic obstructive pulmonary disease	0.00167	0.083	CbGeAlD
Rasagiline—BCL2—Overview of nanoparticle effects—CRP—chronic obstructive pulmonary disease	0.00158	0.0296	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—RAPGEF3—chronic obstructive pulmonary disease	0.00157	0.0294	CbGpPWpGaD
Rasagiline—MAOB—connective tissue—chronic obstructive pulmonary disease	0.00147	0.073	CbGeAlD
Rasagiline—MAOB—bronchus—chronic obstructive pulmonary disease	0.00138	0.0683	CbGeAlD
Rasagiline—MAOB—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00124	0.0233	CbGpPWpGaD
Rasagiline—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.00119	0.0591	CbGeAlD
Rasagiline—BCL2—ATF-2 transcription factor network—TGFB2—chronic obstructive pulmonary disease	0.00111	0.0209	CbGpPWpGaD
Rasagiline—BCL2—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	0.00102	0.0192	CbGpPWpGaD
Rasagiline—CYP1A2—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000992	0.0186	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—MPO—chronic obstructive pulmonary disease	0.000912	0.0171	CbGpPWpGaD
Rasagiline—MAOB—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000901	0.0169	CbGpPWpGaD
Rasagiline—MAOB—lung—chronic obstructive pulmonary disease	0.000887	0.0441	CbGeAlD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000874	0.0164	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—MMP14—chronic obstructive pulmonary disease	0.000861	0.0162	CbGpPWpGaD
Rasagiline—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000845	0.0159	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—MMP1—chronic obstructive pulmonary disease	0.000814	0.0153	CbGpPWpGaD
Rasagiline—MAOB—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000813	0.0153	CbGpPWpGaD
Rasagiline—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000769	0.0144	CbGpPWpGaD
Rasagiline—BCL2—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000713	0.0134	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—PLAU—chronic obstructive pulmonary disease	0.000632	0.0119	CbGpPWpGaD
Rasagiline—CYP1A2—lung—chronic obstructive pulmonary disease	0.000632	0.0314	CbGeAlD
Rasagiline—BCL2—TP53 Network—TP53—chronic obstructive pulmonary disease	0.000629	0.0118	CbGpPWpGaD
Rasagiline—BCL2—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—chronic obstructive pulmonary disease	0.000594	0.0112	CbGpPWpGaD
Rasagiline—MAOB—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000591	0.0111	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—NOS2—chronic obstructive pulmonary disease	0.00058	0.0109	CbGpPWpGaD
Rasagiline—BCL2—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000576	0.0108	CbGpPWpGaD
Rasagiline—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000573	0.0108	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.000571	0.0107	CbGpPWpGaD
Rasagiline—BCL2—RXR and RAR heterodimerization with other nuclear receptor—TNF—chronic obstructive pulmonary disease	0.000555	0.0104	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00052	0.00976	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000514	0.00964	CbGpPWpGaD
Rasagiline—BCL2—Activation of BH3-only proteins—TP53—chronic obstructive pulmonary disease	0.000505	0.00948	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—HDAC2—chronic obstructive pulmonary disease	0.0005	0.00939	CbGpPWpGaD
Rasagiline—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000486	0.00911	CbGpPWpGaD
Rasagiline—BCL2—IL-3 Signaling Pathway—CXCL8—chronic obstructive pulmonary disease	0.00048	0.00901	CbGpPWpGaD
Rasagiline—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000466	0.00875	CbGpPWpGaD
Rasagiline—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—chronic obstructive pulmonary disease	0.000459	0.00861	CbGpPWpGaD
Rasagiline—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000442	0.0083	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000432	0.00811	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—TLR4—chronic obstructive pulmonary disease	0.000428	0.00803	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—CXCL8—chronic obstructive pulmonary disease	0.000414	0.00777	CbGpPWpGaD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—TNF—chronic obstructive pulmonary disease	0.00041	0.00769	CbGpPWpGaD
Rasagiline—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000406	0.00762	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—PLAU—chronic obstructive pulmonary disease	0.000398	0.00748	CbGpPWpGaD
Rasagiline—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000391	0.00733	CbGpPWpGaD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	0.00039	0.00732	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—PLAU—chronic obstructive pulmonary disease	0.000387	0.00726	CbGpPWpGaD
Rasagiline—BCL2—FAS pathway and Stress induction of HSP regulation—TNF—chronic obstructive pulmonary disease	0.000378	0.0071	CbGpPWpGaD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—TP53—chronic obstructive pulmonary disease	0.000361	0.00678	CbGpPWpGaD
Rasagiline—BCL2—Intrinsic Pathway for Apoptosis—TP53—chronic obstructive pulmonary disease	0.000361	0.00678	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00036	0.00676	CbGpPWpGaD
Rasagiline—BCL2—IL-3 Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	0.000358	0.00672	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—LY96—chronic obstructive pulmonary disease	0.000351	0.00659	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000341	0.00641	CbGpPWpGaD
Rasagiline—BCL2—Ceramide signaling pathway—TNF—chronic obstructive pulmonary disease	0.00034	0.00638	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000331	0.00621	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—NOS3—chronic obstructive pulmonary disease	0.000327	0.00614	CbGpPWpGaD
Rasagiline—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000322	0.00604	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000321	0.00603	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000314	0.00589	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—SERPINE1—chronic obstructive pulmonary disease	0.000308	0.00578	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	0.000303	0.0057	CbGpPWpGaD
Rasagiline—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000302	0.00566	CbGpPWpGaD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—TNF—chronic obstructive pulmonary disease	0.000296	0.00556	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—CXCL8—chronic obstructive pulmonary disease	0.00029	0.00545	CbGpPWpGaD
Rasagiline—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000283	0.00129	CcSEcCtD
Rasagiline—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000283	0.00129	CcSEcCtD
Rasagiline—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000283	0.00129	CcSEcCtD
Rasagiline—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000283	0.00129	CcSEcCtD
Rasagiline—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000282	0.00129	CcSEcCtD
Rasagiline—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000282	0.00129	CcSEcCtD
Rasagiline—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.00129	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.00129	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000282	0.00129	CcSEcCtD
Rasagiline—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.000281	0.00129	CcSEcCtD
Rasagiline—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00028	0.00128	CcSEcCtD
Rasagiline—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00028	0.00128	CcSEcCtD
Rasagiline—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000278	0.00127	CcSEcCtD
Rasagiline—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000277	0.00127	CcSEcCtD
Rasagiline—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000277	0.00127	CcSEcCtD
Rasagiline—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000277	0.00127	CcSEcCtD
Rasagiline—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000276	0.00127	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000276	0.00126	CcSEcCtD
Rasagiline—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000275	0.00126	CcSEcCtD
Rasagiline—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000274	0.00126	CcSEcCtD
Rasagiline—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000274	0.00125	CcSEcCtD
Rasagiline—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.00124	CcSEcCtD
Rasagiline—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000271	0.00124	CcSEcCtD
Rasagiline—Infection—Formoterol—chronic obstructive pulmonary disease	0.00027	0.00124	CcSEcCtD
Rasagiline—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00027	0.00124	CcSEcCtD
Rasagiline—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.00123	CcSEcCtD
Rasagiline—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.00123	CcSEcCtD
Rasagiline—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000268	0.00122	CcSEcCtD
Rasagiline—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.00122	CcSEcCtD
Rasagiline—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000267	0.00122	CcSEcCtD
Rasagiline—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000267	0.00122	CcSEcCtD
Rasagiline—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000266	0.00122	CcSEcCtD
Rasagiline—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000265	0.00121	CcSEcCtD
Rasagiline—Infection—Montelukast—chronic obstructive pulmonary disease	0.000264	0.00121	CcSEcCtD
Rasagiline—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000264	0.00121	CcSEcCtD
Rasagiline—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000264	0.00121	CcSEcCtD
Rasagiline—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000264	0.00121	CcSEcCtD
Rasagiline—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000263	0.0012	CcSEcCtD
Rasagiline—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000262	0.0012	CcSEcCtD
Rasagiline—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000261	0.0012	CcSEcCtD
Rasagiline—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000261	0.00119	CcSEcCtD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—CXCL8—chronic obstructive pulmonary disease	0.000261	0.0049	CbGpPWpGaD
Rasagiline—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000259	0.00118	CcSEcCtD
Rasagiline—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000255	0.00117	CcSEcCtD
Rasagiline—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000254	0.00116	CcSEcCtD
Rasagiline—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000254	0.00116	CcSEcCtD
Rasagiline—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000253	0.00116	CcSEcCtD
Rasagiline—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000253	0.00116	CcSEcCtD
Rasagiline—MAOB—Metabolism—APIP—chronic obstructive pulmonary disease	0.000252	0.00474	CbGpPWpGaD
Rasagiline—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000252	0.00115	CcSEcCtD
Rasagiline—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000251	0.00115	CcSEcCtD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IL1B—chronic obstructive pulmonary disease	0.00025	0.0047	CbGpPWpGaD
Rasagiline—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000249	0.00114	CcSEcCtD
Rasagiline—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000248	0.00114	CcSEcCtD
Rasagiline—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000248	0.00114	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.00113	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000248	0.00113	CcSEcCtD
Rasagiline—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000246	0.00113	CcSEcCtD
Rasagiline—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000246	0.00113	CcSEcCtD
Rasagiline—BCL2—Direct p53 effectors—SERPINE1—chronic obstructive pulmonary disease	0.000245	0.0046	CbGpPWpGaD
Rasagiline—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000245	0.00112	CcSEcCtD
Rasagiline—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000244	0.00112	CcSEcCtD
Rasagiline—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000243	0.00111	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000243	0.00111	CcSEcCtD
Rasagiline—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000242	0.00111	CcSEcCtD
Rasagiline—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000242	0.00111	CcSEcCtD
Rasagiline—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000242	0.00111	CcSEcCtD
Rasagiline—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000242	0.00111	CcSEcCtD
Rasagiline—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000241	0.0011	CcSEcCtD
Rasagiline—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00024	0.0011	CcSEcCtD
Rasagiline—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000239	0.0011	CcSEcCtD
Rasagiline—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000239	0.0011	CcSEcCtD
Rasagiline—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000239	0.00109	CcSEcCtD
Rasagiline—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000238	0.00109	CcSEcCtD
Rasagiline—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000237	0.00446	CbGpPWpGaD
Rasagiline—Injury—Prednisone—chronic obstructive pulmonary disease	0.000237	0.00108	CcSEcCtD
Rasagiline—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000237	0.00108	CcSEcCtD
Rasagiline—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000236	0.00108	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000235	0.00107	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.00107	CcSEcCtD
Rasagiline—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000234	0.00107	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00107	CcSEcCtD
Rasagiline—BCL2—ATF-2 transcription factor network—IL6—chronic obstructive pulmonary disease	0.000232	0.00436	CbGpPWpGaD
Rasagiline—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000232	0.00106	CcSEcCtD
Rasagiline—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000232	0.00106	CcSEcCtD
Rasagiline—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.00106	CcSEcCtD
Rasagiline—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000232	0.00106	CcSEcCtD
Rasagiline—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.00105	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00023	0.00105	CcSEcCtD
Rasagiline—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.00105	CcSEcCtD
Rasagiline—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000228	0.00104	CcSEcCtD
Rasagiline—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000228	0.00104	CcSEcCtD
Rasagiline—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000227	0.00104	CcSEcCtD
Rasagiline—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000226	0.00104	CcSEcCtD
Rasagiline—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000226	0.00104	CcSEcCtD
Rasagiline—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000226	0.00103	CcSEcCtD
Rasagiline—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000226	0.00103	CcSEcCtD
Rasagiline—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000225	0.00103	CcSEcCtD
Rasagiline—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000225	0.00103	CcSEcCtD
Rasagiline—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000224	0.00103	CcSEcCtD
Rasagiline—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000224	0.00103	CcSEcCtD
Rasagiline—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000224	0.00103	CcSEcCtD
Rasagiline—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000224	0.00102	CcSEcCtD
Rasagiline—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00102	CcSEcCtD
Rasagiline—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000223	0.00102	CcSEcCtD
Rasagiline—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000223	0.00102	CcSEcCtD
Rasagiline—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000222	0.00102	CcSEcCtD
Rasagiline—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000222	0.00102	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.00101	CcSEcCtD
Rasagiline—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.001	CcSEcCtD
Rasagiline—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000218	0.000996	CcSEcCtD
Rasagiline—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000218	0.000996	CcSEcCtD
Rasagiline—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000218	0.000996	CcSEcCtD
Rasagiline—BCL2—Apoptosis—TNF—chronic obstructive pulmonary disease	0.000217	0.00408	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—TGFB1—chronic obstructive pulmonary disease	0.000216	0.00406	CbGpPWpGaD
Rasagiline—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000216	0.000988	CcSEcCtD
Rasagiline—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.000988	CcSEcCtD
Rasagiline—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000215	0.000983	CcSEcCtD
Rasagiline—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000215	0.000983	CcSEcCtD
Rasagiline—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000215	0.000983	CcSEcCtD
Rasagiline—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000215	0.000983	CcSEcCtD
Rasagiline—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000214	0.00098	CcSEcCtD
Rasagiline—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000214	0.00098	CcSEcCtD
Rasagiline—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000213	0.000973	CcSEcCtD
Rasagiline—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000212	0.000972	CcSEcCtD
Rasagiline—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000212	0.000971	CcSEcCtD
Rasagiline—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000212	0.000971	CcSEcCtD
Rasagiline—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000211	0.000968	CcSEcCtD
Rasagiline—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.000968	CcSEcCtD
Rasagiline—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000211	0.000966	CcSEcCtD
Rasagiline—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00021	0.000963	CcSEcCtD
Rasagiline—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00021	0.000963	CcSEcCtD
Rasagiline—BCL2—Immune System—RAPGEF3—chronic obstructive pulmonary disease	0.00021	0.00394	CbGpPWpGaD
Rasagiline—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.00021	0.000962	CcSEcCtD
Rasagiline—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.000961	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000209	0.00392	CbGpPWpGaD
Rasagiline—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000209	0.00392	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000209	0.00392	CbGpPWpGaD
Rasagiline—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000208	0.000953	CcSEcCtD
Rasagiline—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000207	0.000948	CcSEcCtD
Rasagiline—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000206	0.000944	CcSEcCtD
Rasagiline—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000206	0.00386	CbGpPWpGaD
Rasagiline—BCL2—Immune System—LY96—chronic obstructive pulmonary disease	0.000204	0.00384	CbGpPWpGaD
Rasagiline—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.000933	CcSEcCtD
Rasagiline—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000203	0.00382	CbGpPWpGaD
Rasagiline—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000203	0.000929	CcSEcCtD
Rasagiline—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000203	0.000929	CcSEcCtD
Rasagiline—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.000917	CcSEcCtD
Rasagiline—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.0002	0.000917	CcSEcCtD
Rasagiline—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.0002	0.000916	CcSEcCtD
Rasagiline—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000196	0.000898	CcSEcCtD
Rasagiline—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000195	0.00366	CbGpPWpGaD
Rasagiline—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000195	0.000893	CcSEcCtD
Rasagiline—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000195	0.000893	CcSEcCtD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—TGFB1—chronic obstructive pulmonary disease	0.000195	0.00365	CbGpPWpGaD
Rasagiline—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000192	0.00088	CcSEcCtD
Rasagiline—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000192	0.00088	CcSEcCtD
Rasagiline—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000192	0.000879	CcSEcCtD
Rasagiline—BCL2—Apoptosis—TP53—chronic obstructive pulmonary disease	0.000191	0.00359	CbGpPWpGaD
Rasagiline—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000191	0.000874	CcSEcCtD
Rasagiline—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.000865	CcSEcCtD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—TGFB1—chronic obstructive pulmonary disease	0.000189	0.00354	CbGpPWpGaD
Rasagiline—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000188	0.000862	CcSEcCtD
Rasagiline—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000186	0.000851	CcSEcCtD
Rasagiline—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000186	0.000851	CcSEcCtD
Rasagiline—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.000843	CcSEcCtD
Rasagiline—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000182	0.000834	CcSEcCtD
Rasagiline—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.000831	CcSEcCtD
Rasagiline—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00018	0.000823	CcSEcCtD
Rasagiline—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00018	0.000823	CcSEcCtD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—TP53—chronic obstructive pulmonary disease	0.00018	0.00337	CbGpPWpGaD
Rasagiline—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000176	0.000806	CcSEcCtD
Rasagiline—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.000804	CcSEcCtD
Rasagiline—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000793	CcSEcCtD
Rasagiline—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000173	0.000791	CcSEcCtD
Rasagiline—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000173	0.000791	CcSEcCtD
Rasagiline—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.000784	CcSEcCtD
Rasagiline—Rash—Formoterol—chronic obstructive pulmonary disease	0.000171	0.000784	CcSEcCtD
Rasagiline—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000171	0.000784	CcSEcCtD
Rasagiline—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.000784	CcSEcCtD
Rasagiline—Headache—Formoterol—chronic obstructive pulmonary disease	0.00017	0.000779	CcSEcCtD
Rasagiline—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00017	0.000779	CcSEcCtD
Rasagiline—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000779	CcSEcCtD
Rasagiline—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.000777	CcSEcCtD
Rasagiline—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000169	0.000775	CcSEcCtD
Rasagiline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000169	0.00317	CbGpPWpGaD
Rasagiline—Rash—Montelukast—chronic obstructive pulmonary disease	0.000168	0.000768	CcSEcCtD
Rasagiline—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000168	0.000768	CcSEcCtD
Rasagiline—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.000766	CcSEcCtD
Rasagiline—MAOB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000167	0.00314	CbGpPWpGaD
Rasagiline—Depression—Prednisone—chronic obstructive pulmonary disease	0.000167	0.000765	CcSEcCtD
Rasagiline—Headache—Montelukast—chronic obstructive pulmonary disease	0.000167	0.000763	CcSEcCtD
Rasagiline—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000166	0.00312	CbGpPWpGaD
Rasagiline—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000757	CcSEcCtD
Rasagiline—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000752	CcSEcCtD
Rasagiline—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000752	CcSEcCtD
Rasagiline—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.000747	CcSEcCtD
Rasagiline—MAOB—Metabolism—GC—chronic obstructive pulmonary disease	0.000163	0.00305	CbGpPWpGaD
Rasagiline—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.000744	CcSEcCtD
Rasagiline—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000162	0.000742	CcSEcCtD
Rasagiline—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.000741	CcSEcCtD
Rasagiline—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000162	0.00074	CcSEcCtD
Rasagiline—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00074	CcSEcCtD
Rasagiline—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.000739	CcSEcCtD
Rasagiline—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000161	0.000739	CcSEcCtD
Rasagiline—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.000736	CcSEcCtD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—TP53—chronic obstructive pulmonary disease	0.00016	0.00301	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—TLR2—chronic obstructive pulmonary disease	0.000159	0.00299	CbGpPWpGaD
Rasagiline—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.000726	CcSEcCtD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000159	0.00298	CbGpPWpGaD
Rasagiline—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000158	0.000724	CcSEcCtD
Rasagiline—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.000715	CcSEcCtD
Rasagiline—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.000713	CcSEcCtD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—TP53—chronic obstructive pulmonary disease	0.000155	0.00292	CbGpPWpGaD
Rasagiline—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.000698	CcSEcCtD
Rasagiline—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.000694	CcSEcCtD
Rasagiline—BCL2—Direct p53 effectors—EGFR—chronic obstructive pulmonary disease	0.000152	0.00284	CbGpPWpGaD
Rasagiline—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000693	CcSEcCtD
Rasagiline—MAOB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000151	0.00284	CbGpPWpGaD
Rasagiline—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000689	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—KL—chronic obstructive pulmonary disease	0.00015	0.00281	CbGpPWpGaD
Rasagiline—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000686	CcSEcCtD
Rasagiline—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000677	CcSEcCtD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IL6—chronic obstructive pulmonary disease	0.000147	0.00275	CbGpPWpGaD
Rasagiline—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000145	0.000663	CcSEcCtD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000143	0.00268	CbGpPWpGaD
Rasagiline—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.000143	0.00268	CbGpPWpGaD
Rasagiline—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.000651	CcSEcCtD
Rasagiline—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000644	CcSEcCtD
Rasagiline—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000137	0.00257	CbGpPWpGaD
Rasagiline—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000625	CcSEcCtD
Rasagiline—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000622	CcSEcCtD
Rasagiline—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.000609	CcSEcCtD
Rasagiline—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000609	CcSEcCtD
Rasagiline—BCL2—Apoptosis—TNF—chronic obstructive pulmonary disease	0.000133	0.0025	CbGpPWpGaD
Rasagiline—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.000605	CcSEcCtD
Rasagiline—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000604	CcSEcCtD
Rasagiline—BCL2—Focal Adhesion—VEGFA—chronic obstructive pulmonary disease	0.000132	0.00248	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000131	0.00247	CbGpPWpGaD
Rasagiline—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000131	0.0006	CcSEcCtD
Rasagiline—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.000131	0.00246	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—TP53—chronic obstructive pulmonary disease	0.000127	0.00239	CbGpPWpGaD
Rasagiline—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000557	CcSEcCtD
Rasagiline—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.000555	CcSEcCtD
Rasagiline—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000554	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000121	0.00226	CbGpPWpGaD
Rasagiline—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000551	CcSEcCtD
Rasagiline—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00012	0.00226	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.00012	0.00225	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000119	0.00223	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—EGFR—chronic obstructive pulmonary disease	0.000119	0.00223	CbGpPWpGaD
Rasagiline—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000541	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000118	0.00222	CbGpPWpGaD
Rasagiline—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000539	CcSEcCtD
Rasagiline—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000538	CcSEcCtD
Rasagiline—BCL2—Apoptosis—TP53—chronic obstructive pulmonary disease	0.000117	0.0022	CbGpPWpGaD
Rasagiline—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000535	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	0.000115	0.00217	CbGpPWpGaD
Rasagiline—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000527	CcSEcCtD
Rasagiline—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000114	0.00052	CcSEcCtD
Rasagiline—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000518	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000113	0.00211	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	0.000112	0.00211	CbGpPWpGaD
Rasagiline—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000511	CcSEcCtD
Rasagiline—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000509	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000507	CcSEcCtD
Rasagiline—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000505	CcSEcCtD
Rasagiline—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000496	CcSEcCtD
Rasagiline—Infection—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000486	CcSEcCtD
Rasagiline—Shock—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000482	CcSEcCtD
Rasagiline—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000105	0.00048	CcSEcCtD
Rasagiline—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000476	CcSEcCtD
Rasagiline—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000473	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—CRP—chronic obstructive pulmonary disease	0.000103	0.00193	CbGpPWpGaD
Rasagiline—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000467	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	9.92e-05	0.00186	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—TLR4—chronic obstructive pulmonary disease	9.84e-05	0.00185	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	9.77e-05	0.00183	CbGpPWpGaD
Rasagiline—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	9.75e-05	0.000446	CcSEcCtD
Rasagiline—Dizziness—Prednisolone—chronic obstructive pulmonary disease	9.73e-05	0.000446	CcSEcCtD
Rasagiline—Insomnia—Prednisone—chronic obstructive pulmonary disease	9.67e-05	0.000443	CcSEcCtD
Rasagiline—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	9.61e-05	0.00044	CcSEcCtD
Rasagiline—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	9.42e-05	0.000431	CcSEcCtD
Rasagiline—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	9.3e-05	0.000426	CcSEcCtD
Rasagiline—Rash—Prednisolone—chronic obstructive pulmonary disease	9.28e-05	0.000425	CcSEcCtD
Rasagiline—BCL2—Immune System—TLR2—chronic obstructive pulmonary disease	9.28e-05	0.00174	CbGpPWpGaD
Rasagiline—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	9.27e-05	0.000424	CcSEcCtD
Rasagiline—Headache—Prednisolone—chronic obstructive pulmonary disease	9.22e-05	0.000422	CcSEcCtD
Rasagiline—Constipation—Prednisone—chronic obstructive pulmonary disease	9.15e-05	0.000419	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	8.97e-05	0.00168	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.89e-05	0.00167	CbGpPWpGaD
Rasagiline—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	8.81e-05	0.000403	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	8.79e-05	0.00165	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	8.79e-05	0.00165	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GCLC—chronic obstructive pulmonary disease	8.79e-05	0.00165	CbGpPWpGaD
Rasagiline—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	8.75e-05	0.0004	CcSEcCtD
Rasagiline—Nausea—Prednisolone—chronic obstructive pulmonary disease	8.74e-05	0.0004	CcSEcCtD
Rasagiline—BCL2—Immune System—KL—chronic obstructive pulmonary disease	8.73e-05	0.00164	CbGpPWpGaD
Rasagiline—Urticaria—Prednisone—chronic obstructive pulmonary disease	8.5e-05	0.000389	CcSEcCtD
Rasagiline—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	8.46e-05	0.000387	CcSEcCtD
Rasagiline—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	8.46e-05	0.000387	CcSEcCtD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.45e-05	0.00159	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	8.37e-05	0.00157	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	8.37e-05	0.00157	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.34e-05	0.00157	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.22e-05	0.00154	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CTGF—chronic obstructive pulmonary disease	8.02e-05	0.0015	CbGpPWpGaD
Rasagiline—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	7.88e-05	0.000361	CcSEcCtD
Rasagiline—Asthenia—Prednisone—chronic obstructive pulmonary disease	7.67e-05	0.000351	CcSEcCtD
Rasagiline—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.66e-05	0.00144	CbGpPWpGaD
Rasagiline—Pruritus—Prednisone—chronic obstructive pulmonary disease	7.57e-05	0.000346	CcSEcCtD
Rasagiline—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.56e-05	0.00142	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.39e-05	0.00139	CbGpPWpGaD
Rasagiline—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	7.32e-05	0.000335	CcSEcCtD
Rasagiline—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.26e-05	0.00136	CbGpPWpGaD
Rasagiline—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.16e-05	0.00134	CbGpPWpGaD
Rasagiline—Dizziness—Prednisone—chronic obstructive pulmonary disease	7.07e-05	0.000324	CcSEcCtD
Rasagiline—BCL2—Immune System—CD8A—chronic obstructive pulmonary disease	7.03e-05	0.00132	CbGpPWpGaD
Rasagiline—Vomiting—Prednisone—chronic obstructive pulmonary disease	6.8e-05	0.000311	CcSEcCtD
Rasagiline—Rash—Prednisone—chronic obstructive pulmonary disease	6.74e-05	0.000309	CcSEcCtD
Rasagiline—Dermatitis—Prednisone—chronic obstructive pulmonary disease	6.74e-05	0.000308	CcSEcCtD
Rasagiline—Headache—Prednisone—chronic obstructive pulmonary disease	6.7e-05	0.000307	CcSEcCtD
Rasagiline—BCL2—Immune System—ERBB3—chronic obstructive pulmonary disease	6.54e-05	0.00123	CbGpPWpGaD
Rasagiline—Nausea—Prednisone—chronic obstructive pulmonary disease	6.35e-05	0.000291	CcSEcCtD
Rasagiline—MAOB—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.16e-05	0.00116	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.08e-05	0.00114	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CRP—chronic obstructive pulmonary disease	5.98e-05	0.00112	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	5.84e-05	0.0011	CbGpPWpGaD
Rasagiline—BCL2—Immune System—TLR4—chronic obstructive pulmonary disease	5.73e-05	0.00108	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.66e-05	0.00106	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.37e-05	0.00101	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—EGFR—chronic obstructive pulmonary disease	4.88e-05	0.000916	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.17e-05	0.000782	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.87e-05	0.000727	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	3.77e-05	0.000707	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—IL6—chronic obstructive pulmonary disease	3.75e-05	0.000704	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL1B—chronic obstructive pulmonary disease	3.73e-05	0.0007	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ALB—chronic obstructive pulmonary disease	3.65e-05	0.000685	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.5e-05	0.000657	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—NOS3—chronic obstructive pulmonary disease	3.49e-05	0.000655	CbGpPWpGaD
Rasagiline—BCL2—Immune System—EGFR—chronic obstructive pulmonary disease	2.84e-05	0.000534	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.79e-05	0.000524	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL6—chronic obstructive pulmonary disease	2.18e-05	0.00041	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.06e-05	0.000386	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.03e-05	0.000382	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.9e-05	0.000356	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.86e-05	0.000348	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.43e-05	0.000268	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.41e-05	0.000264	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.31e-05	0.000246	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.24e-05	0.000233	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	8.44e-06	0.000158	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	8.08e-06	0.000152	CbGpPWpGaD
